Voloridge Investment Management LLC Makes New Investment in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Voloridge Investment Management LLC bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 397,734 shares of the company's stock, valued at approximately $15,770,000. Voloridge Investment Management LLC owned about 0.43% of Acadia Healthcare as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of ACHC. Lindbrook Capital LLC increased its holdings in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after acquiring an additional 671 shares in the last quarter. Blue Trust Inc. increased its holdings in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after acquiring an additional 345 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares during the period. Signaturefd LLC boosted its position in shares of Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after acquiring an additional 454 shares during the last quarter.

Acadia Healthcare Trading Down 0.7%

ACHC stock traded down $0.15 during midday trading on Thursday, reaching $22.60. The company's stock had a trading volume of 197,721 shares, compared to its average volume of 1,716,830. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of 7.41, a PEG ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The stock has a fifty day simple moving average of $25.33 and a two-hundred day simple moving average of $34.56.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. During the same quarter last year, the company earned $0.84 earnings per share. The firm's revenue for the quarter was up .3% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho lowered their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. KeyCorp lowered their price target on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Royal Bank of Canada lowered their price target on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Finally, Guggenheim started coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.